Premium
Transcatheter valves are a viable option for degenerative surgical mitral bioprostheses
Author(s) -
Khan Asaad,
Dangas George
Publication year - 2019
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28285
Subject(s) - medicine , percutaneous , mitral valve , surgery , cardiology , mitral valve replacement
Key Points Repeat surgery is the ideal choice for degenerated bioprosthetic mitral valves. Percutaneous valve‐in‐valve (ViV) replacement for the treatment of degenerated bioprostheses has emerged as an alternative to open surgery in patients who are at high risk of surgical complications. Joseph et al have described the feasibility and long‐term outcomes of Melody ViV Implantation for bioprosthetic mitral valve dysfunction in high‐risk population.